Clinical reasoning and prevention of cardiovascular disease

Area of Science:

• Cardiology
• Preventive Medicine
• Clinical Reasoning

Background:

• Major lipid prevention guidelines utilize 10-year cardiovascular event risk and LDL cholesterol (LDL-C) for initiating and monitoring statin therapy.
• These established principles are supported by extensive observational studies and randomized clinical trials, representing significant advancements in cardiovascular disease prevention.
• However, potential limitations in the current risk-based model necessitate re-evaluation for enhanced cardiovascular prevention strategies.

Observation:

• The current paradigm focuses on population-level risk stratification and LDL-C reduction as primary therapeutic goals.
• Clinical reasoning, integrating diverse knowledge domains like physiology, pathology, and clinical experience, is crucial for individualized patient care.
• A single case analysis highlights the complexities and potential shortcomings of solely relying on risk scores and LDL-C targets.

Findings:

• The universal practice of linking clinical outcomes of lipid-lowering trials solely to LDL-C reduction may obscure other contributing factors.
• A shift from a 'Risk model' to a 'Causal Benefit model' is proposed for a more nuanced approach to cardiovascular prevention.
• Individualized decision-making, grounded in comprehensive clinical reasoning, is paramount for effective patient care.

Implications:

• Revising the approach to cardiovascular prevention could lead to more personalized and effective treatment strategies.
• Understanding causal benefits beyond LDL-C reduction may optimize statin therapy and other interventions.
• This perspective encourages a move towards a more holistic and case-specific approach in managing cardiovascular disease risk.